Get started
Author

Amna Aslam

Observed names: A Aslam, Amna M. Aslam, Anosha Muhammad Aslam
ORCID: 0009-0005-3646-6982
Observed ORCID: 0009-0005-3646-6982
OpenAlex ID: A5080631045
Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends
2025 · Amna M. Aslam, Kenneth Shinozuka, et al. · American Journal of Therapeutics · 7
Prevalence of Overweight and Obesity in Infants and Their Association with Breastfeeding Practices
2026 · Ariba Siddiqui, Rozina Muhammad Iqbal, et al. · Journal of College of Physicians And Surgeons Pakistan
Beyond the PHQ-9 and Into the DSM-XC: Transdiagnostic and Functional Assessment of Accelerated TMS Outcomes
2025 · Amna Aslam, Carlene MacMillan, et al. · Transcranial magnetic stimulation .
PDF
Resolution of Aphasia and Gait Instability in a Patient With HSV Encephalitis After dTMS Treatment: A Case Report
2025 · Amna Aslam, Owen Muir, et al. · Transcranial magnetic stimulation .
PDF
Successful Dtms in Rtms, Ect, and Ketamine Refractory Depression: a Case Series
2024 · Amna Aslam, Irfan Handoo, et al. · Transcranial magnetic stimulation .
PDF
HSD57 Current Status of Off-Label IV Ketamine Utilization for Mood Disorders: A Nationwide Survey of Ketamine Clinics, Treatment Processes, and Provider Perceptions of Outcomes
2024 · A Aslam, S Prashad, et al. · Value in Health
PDF
RWD119 Do Long-Acting Injectable Antipsychotics (LAIS) Lower Hospital Utilization and Deliver Superior Economic Outcomes in Schizophrenia (SCZ)? a Systematic Review of Real-World Evidence (RWE)
2022 · A Aslam, R Nayak · Value in Health
PDF
RWD92 Adherence Advantages of Long-Acting Injectable Antipsychotics (LAIS) in Schizophrenia. Is the Currently Available Real-World Evidence Adequate or Conclusive?
2022 · A Aslam, R Nayak · Value in Health
Works count: 8
Citation count: 7
H-index: 1
I10-index:
Year
Topic
Type